ALBERTDAVDBSEAlbert David Ltd-$MinimalNeutral
Announced Wed, 13 May · 12:55 IST

Newspaper publication of Extract of Audited Financial Result for the fourth quarter and year ended 31st March, 2026

ALBERTDAVD · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-10.5%1-day move
₹790.00
prior close
₹722.05
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0-0.8-0.7-0.7-10.5-8.6-10.1-9.2-10.4-10.6-8.8-8.3-11.2
Up moveDown movePending
AI summary

Albert David Limited, a Kothari Group pharmaceutical manufacturer, reported Total Income from Operations of Rs. 33,359.81 Lakhs for FY26, slightly lower than Rs. 34,576.80 Lakhs in FY25. However, net profit surged significantly to Rs. 110.40 Lakhs in FY26 from Rs. 12.50 Lakhs in FY25. For Q4 FY26 alone, the company posted total income of Rs. 586.34 Lakhs and net profit of Rs. 12.70 Lakhs, compared to Rs. 7,489.33 Lakhs and Rs. 4.68 Lakhs respectively in Q4 FY25. Basic EPS for FY26 (annualised) stands at Rs. 14.68 versus Rs. 1.67 in FY25. The Board has recommended a dividend of Rs. 5 per equity share of Rs. 10 face value. Results were approved on May 12, 2026 with an unmodified audit opinion from statutory auditors.

Likely market impact

The sharp increase in net profit and EPS despite marginally lower revenue indicates improved operational efficiency. The dividend recommendation is positive for shareholders. The stock may see positive reaction given the strong profit growth year-on-year.